Cargando…

Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice

MDMA (3,4-methylenedioxymethamphetamine) is a psychostimulant popular as a recreational drug because of its effect on mood and social interactions. MDMA acts at dopamine (DA) transporter (DAT) and serotonin (5-HT) transporter (SERT) and is known to induce damage of dopamine and serotonin neurons. MD...

Descripción completa

Detalles Bibliográficos
Autores principales: Górska, Anna Maria, Kamińska, Katarzyna, Wawrzczak-Bargieła, Agnieszka, Costa, Giulia, Morelli, Micaela, Przewłocki, Ryszard, Kreiner, Grzegorz, Gołembiowska, Krystyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871650/
https://www.ncbi.nlm.nih.gov/pubmed/29134560
http://dx.doi.org/10.1007/s12640-017-9831-9
_version_ 1783309668582424576
author Górska, Anna Maria
Kamińska, Katarzyna
Wawrzczak-Bargieła, Agnieszka
Costa, Giulia
Morelli, Micaela
Przewłocki, Ryszard
Kreiner, Grzegorz
Gołembiowska, Krystyna
author_facet Górska, Anna Maria
Kamińska, Katarzyna
Wawrzczak-Bargieła, Agnieszka
Costa, Giulia
Morelli, Micaela
Przewłocki, Ryszard
Kreiner, Grzegorz
Gołembiowska, Krystyna
author_sort Górska, Anna Maria
collection PubMed
description MDMA (3,4-methylenedioxymethamphetamine) is a psychostimulant popular as a recreational drug because of its effect on mood and social interactions. MDMA acts at dopamine (DA) transporter (DAT) and serotonin (5-HT) transporter (SERT) and is known to induce damage of dopamine and serotonin neurons. MDMA is often ingested with caffeine. Caffeine as a non-selective adenosine A1/A2A receptor antagonist affects dopaminergic and serotonergic transmissions. The aim of the present study was to determine the changes in DA and 5-HT release in the mouse striatum induced by MDMA and caffeine after their chronic administration. To find out whether caffeine aggravates MDMA neurotoxicity, the content of DA and 5-HT, density of brain DAT and SERT, and oxidative damage of nuclear DNA were determined. Furthermore, the effect of caffeine on MDMA-induced changes in striatal dynorphin and enkephalin and on behavior was assessed. The DA and 5-HT release was determined with in vivo microdialysis, and the monoamine contents were measured by HPLC with electrochemical detection. DNA damage was assayed with the alkaline comet assay. DAT and SERT densities were determined by immunohistochemistry, while prodynorphin (PDYN) and proenkephalin were determined by quantitative PCR reactions. The behavioral changes were measured by the open-field (OF) test and novel object recognition (NOR) test. Caffeine potentiated MDMA-induced DA release while inhibiting 5-HT release in the mouse striatum. Caffeine also exacerbated the oxidative damage of nuclear DNA induced by MDMA but diminished DAT decrease in the striatum and worsened a decrease in SERT density produced by MDMA in the frontal cortex. Neither the striatal PDYN expression, increased by MDMA, nor exploratory and locomotor activities of mice, decreased by MDMA, were affected by caffeine. The exploration of novel object in the NOR test was diminished by MDMA and caffeine. Our data provide evidence that long-term caffeine administration has a powerful influence on functions of dopaminergic and serotonergic neurons in the mouse brain and on neurotoxic effects evoked by MDMA.
format Online
Article
Text
id pubmed-5871650
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-58716502018-03-28 Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice Górska, Anna Maria Kamińska, Katarzyna Wawrzczak-Bargieła, Agnieszka Costa, Giulia Morelli, Micaela Przewłocki, Ryszard Kreiner, Grzegorz Gołembiowska, Krystyna Neurotox Res Original Article MDMA (3,4-methylenedioxymethamphetamine) is a psychostimulant popular as a recreational drug because of its effect on mood and social interactions. MDMA acts at dopamine (DA) transporter (DAT) and serotonin (5-HT) transporter (SERT) and is known to induce damage of dopamine and serotonin neurons. MDMA is often ingested with caffeine. Caffeine as a non-selective adenosine A1/A2A receptor antagonist affects dopaminergic and serotonergic transmissions. The aim of the present study was to determine the changes in DA and 5-HT release in the mouse striatum induced by MDMA and caffeine after their chronic administration. To find out whether caffeine aggravates MDMA neurotoxicity, the content of DA and 5-HT, density of brain DAT and SERT, and oxidative damage of nuclear DNA were determined. Furthermore, the effect of caffeine on MDMA-induced changes in striatal dynorphin and enkephalin and on behavior was assessed. The DA and 5-HT release was determined with in vivo microdialysis, and the monoamine contents were measured by HPLC with electrochemical detection. DNA damage was assayed with the alkaline comet assay. DAT and SERT densities were determined by immunohistochemistry, while prodynorphin (PDYN) and proenkephalin were determined by quantitative PCR reactions. The behavioral changes were measured by the open-field (OF) test and novel object recognition (NOR) test. Caffeine potentiated MDMA-induced DA release while inhibiting 5-HT release in the mouse striatum. Caffeine also exacerbated the oxidative damage of nuclear DNA induced by MDMA but diminished DAT decrease in the striatum and worsened a decrease in SERT density produced by MDMA in the frontal cortex. Neither the striatal PDYN expression, increased by MDMA, nor exploratory and locomotor activities of mice, decreased by MDMA, were affected by caffeine. The exploration of novel object in the NOR test was diminished by MDMA and caffeine. Our data provide evidence that long-term caffeine administration has a powerful influence on functions of dopaminergic and serotonergic neurons in the mouse brain and on neurotoxic effects evoked by MDMA. Springer US 2017-11-13 2018 /pmc/articles/PMC5871650/ /pubmed/29134560 http://dx.doi.org/10.1007/s12640-017-9831-9 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Górska, Anna Maria
Kamińska, Katarzyna
Wawrzczak-Bargieła, Agnieszka
Costa, Giulia
Morelli, Micaela
Przewłocki, Ryszard
Kreiner, Grzegorz
Gołembiowska, Krystyna
Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice
title Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice
title_full Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice
title_fullStr Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice
title_full_unstemmed Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice
title_short Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice
title_sort neurochemical and neurotoxic effects of mdma (ecstasy) and caffeine after chronic combined administration in mice
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871650/
https://www.ncbi.nlm.nih.gov/pubmed/29134560
http://dx.doi.org/10.1007/s12640-017-9831-9
work_keys_str_mv AT gorskaannamaria neurochemicalandneurotoxiceffectsofmdmaecstasyandcaffeineafterchroniccombinedadministrationinmice
AT kaminskakatarzyna neurochemicalandneurotoxiceffectsofmdmaecstasyandcaffeineafterchroniccombinedadministrationinmice
AT wawrzczakbargiełaagnieszka neurochemicalandneurotoxiceffectsofmdmaecstasyandcaffeineafterchroniccombinedadministrationinmice
AT costagiulia neurochemicalandneurotoxiceffectsofmdmaecstasyandcaffeineafterchroniccombinedadministrationinmice
AT morellimicaela neurochemicalandneurotoxiceffectsofmdmaecstasyandcaffeineafterchroniccombinedadministrationinmice
AT przewłockiryszard neurochemicalandneurotoxiceffectsofmdmaecstasyandcaffeineafterchroniccombinedadministrationinmice
AT kreinergrzegorz neurochemicalandneurotoxiceffectsofmdmaecstasyandcaffeineafterchroniccombinedadministrationinmice
AT gołembiowskakrystyna neurochemicalandneurotoxiceffectsofmdmaecstasyandcaffeineafterchroniccombinedadministrationinmice